Combining CAR-T therapy with radiotherapy or not in refractory/relapsed diffuse large B-cell lymphoma: A comparative study
Our analysis demonstrated that BRT is an effective and safe approach for patients with R/R DLBCL preparing for CAR T-cell therapy, which indicated that BRT may enhance the anti-tumor effect of CAR T-cells.
Authors
- Yun Yang (ORCID: https://orcid.org/0000-0002-6314-0516)
- Aibin Liang (ORCID: https://orcid.org/0000-0002-8978-1987)
- Bichun Xu
- Judong Luo
- Hong Zhu (ORCID: https://orcid.org/0000-0002-3659-8070)
- Weikai Sun
Institutions
- Tongji University (CN)
- Tongji Hospital (CN)
Publication Details
- Journal
- Clinical and Translational Radiation Oncology
- Published
- 2025-09-02
- DOI
- https://doi.org/10.1016/j.ctro.2025.101041
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Tongji Hospital